| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5509585 | Clinica Chimica Acta | 2017 | 4 Pages |
Abstract
A dabrafenib trough plasma threshold of 48Â ng/ml can predict the occurrence of adverse events requiring dose reduction.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Marine Rousset, Caroline Dutriaux, Pauline Bosco-Lévy, Sorilla Prey, Anne Pham-Ledard, Léa Dousset, Emilie Gérard, Stephane Bouchet, Mireille Canal-Raffin, Karine Titier, Mathieu Molimard,